The Rundown: ExL’s Blog
Viewing 71 to 80 of 103 records.
The Benefits of Clinical Trials for Cancer Patients, According to a Survivor
Friday June 2nd, 2017
Twelve years after T.J. Sharpe’s successful melanoma surgery, the husband and father-of-two saw the return of his skin cancer. Faced once again with the unexpected realization of mortality after more than a decade of remission, a clinical trial helped ensure Sharpe would see his children grow up. This patient and survivor is helping spread the word about clinical trials, and how they should be an available option for others like him.
The return of Sharpe’s melanoma was accompanied by a predicted life expectancy of less than two years. He was adamant on…
Top 10 U.S. Pharma Patent Losses of 2017
Monday May 29th, 2017
As we come approach the midway mark of 2017, we can’t help but wonder how the passage of time is affecting the pharmaceutical industry. Regarding U.S. patents on certain drugs, some big-name pharma companies are looking at big-time losses in 2017. Companies like Takeda, Pfizer, Gilead, Eli Lilly, and Bristol-Myers Squibb are doing their best to hold onto these coveted drug patents, but odds are that they won’t have such great luck. According to a recently published content report from FiercePharma, a handful of popular drug patents in the U.S. are expiring.
To give you an idea…
Top 10 Pharma R&D Budgets
Monday May 22nd, 2017
Since drug pricing was a noted talking point of the 2016 presidential election, it might not come as a surprise that R&D budgets in the pharmaceutical industry have seen big cuts as a result. And while this comes across as a negative, reduced spending on pharma R&D – though resulting in staff cuts, restructured operations, and more – actually resulted in positive percentage terms in sales. Luckily for us, FierceBiotech has made this information easy to understand in a recently published content report.
R&D spending varied from company to company, but overall,…
ExL Partners with the Medical Affairs Professional Society (MAPS)!
Thursday May 18th, 2017
ExL Events is excited to announce that we’ve been selected as the exclusive conference partner on a series of promotional, event service, and content exchange with the Medical Affairs Professional Society (MAPS)! While MAPS is a relatively new association, it has proved itself as one of the most formidable organizations in the medical affairs segment. MAPS has been impressing the ExL team since we started covering it in the early 2000s. Find out more about our new partner below!
ExL Events’ co-founder and COO, Ethan Denkensohn, had this to say about the exciting…
Senate Confirms New Head of FDA: Two-Time ExL Speaker Dr. Scott Gottlieb
Monday May 15th, 2017
ExL Events would like to congratulate our speaker alumnus Dr. Scott Gottlieb for the recent United States Senate confirmation, naming him the new Food and Drug Administration commissioner. Dr. Gottlieb was the keynote speaker at ExL’s 2nd Trial Design Innovation Conference and was also a featured speaker at our Private Fee-for-Service event.
President Donald Trump nominated Gottlieb earlier this year, for his previous service as deputy commissioner for the FDA, as well as his experience in the pharmaceutical and health care industries. As the FDA’s newly appointed commissioner, Gottlieb will…
Key Stakeholders Gather This Fall to Discuss Abuse-Deterrent Formulations, Regulations and Policies
Tuesday October 18th, 2016
|Dan Cohen, Forum Chair, Abuse Deterrent Coalition|
This guest blog post is written by Dan Cohen, the Forum Chair of the Abuse Deterrent Coalition and speaker at the 3rd Human Abuse Liability & Abuse-Deterrent Formulations conference, which takes place in Arlington, VA this November 2-3.
The prominence of Abuse Deterrent Formulations (ADF) in the public policy debate has never been greater. This fall is no exception as we are now at yet another critical juncture for the ADF sector, with…
Questex Acquires ExL Events
Monday July 11th, 2016
Acquisition of Leading Life Sciences Event Company Expands Company’s Services in Pharmaceutical, Life Science and Healthcare Markets
Questex, a leading global business information and events company, today announced it has acquired ExL Events, Inc., expanding Questex’s presence in the global pharmaceutical, life science and healthcare markets.
ExL Events, founded in 2004 as ExL Pharma, is the industry leader in developing innovative, educational conferences that serve the pharmaceutical, life science and healthcare communities. Kerry Gumas, Questex President and Chief Executive Officer,…
Four Content Marketing Tips for Pharma
Thursday November 12th, 2015
Content marketing is one of the most effective tools life science professionals have in their arsenal. Developing an effective campaign, however, can be difficult. We’ve put together these simple tips to help guide you in the right direction.
Tip #1: Know Your Audience.
Before you start creating content, be sure you know the answer to this simple question: Who are you trying to reach? Keeping your target audience in mind as you create content can be the difference between a successful campaign and one that falls short. For instance,…
PR Experts Shed Light On… (Part Two)
Thursday November 5th, 2015
This guest blog post is a continuation of last week’s PR Experts Shed Light On… (Part One) article. Dave Hochman, owner of the Red Bank, NJ-based DJH Marketing Communications, Inc., spoke to faculty members from the 11th Public Relations & Communications Summit about the opportunities and challenges pharma PR professionals face.
To learn more about Dave, visit www.djhmarcom.com, email him at email@example.com or follow him on Twitter @davehochman.
Q: What can other industries look to pharma for right now in terms of ideas and inspiration beyond endorsements and collaborations…
PR Experts Shed Light On… (Part One)
Wednesday October 28th, 2015
This guest blog post is written by Dave Hochman, and is part one of an interview Dave performed following the 11th Public Relations & Communications Summit in July 2015.
Dave is the owner of the Red Bank, NJ-based DJH Marketing Communications, Inc. To learn more about Dave, visit www.djhmarcom.com, email him at firstname.lastname@example.org or follow him on Twitter @davehochman.
After the 11th Public Relations & Communications Summit took place in July, we were fortunate enough to be able to circle back with some of the…
From The Blog
- Commercial Strategy
- Content Marketing
- Data Management
- Digital Marketing
- Drug Safety
- Emerging Markets
- ExL Events News
- Medical Devices
- Medical Education
- Meeting Planning
- Patient Engagement
- Public/Government Relations
- Regulatory Affairs